Delalutin and ebstein's anomaly Patient Reports February 09, 2012

Delalutin Side Effects Report #5368836-0
Delalutin side effect was reported by a Health Professional from UNITED STATES on June 21, 2007. Male patient, weighting 6.00 lb, was diagnosed with ovarian failure and was treated with Delalutin. After drug was administered, patient experienced the following side effects: alcohol interaction, atrial septal defect, atrioventricular septal defect, chromosomal deletion, ebstein's anomaly. Delalutin dosage: 250 MG 1 INJECTION/WEEK IM. During the same period patient was treated with ALCOHOL. Patient was hospitalized. Patient recovered.

Delalutin Side Effects Report #6093715-3
Delalutin side effect was reported by a Health Professional from UNITED STATES on Feb 23, 2009. Male patient, weighting 6.00 lb, was diagnosed with luteal phase deficiency and was treated with Delalutin. After drug was administered, patient experienced the following side effects: alcohol interaction, chromosomal deletion, ebstein's anomaly, heart disease congenital, microcephaly. Delalutin dosage: 250 MG ONCE A WEEK IM. Patient was hospitalized. Patient recovered.

Delalutin Side Effects Report #5419046-X
Delalutin side effect was reported by a Health Professional from UNITED STATES on Aug 17, 2007. Male patient, weighting 6.00 lb, was treated with Delalutin. After drug was administered, patient experienced the following side effects: alcohol interaction, atrial septal defect, atrioventricular septal defect, chromosomal deletion, ebstein's anomaly. Delalutin dosage: 250 MG 1 INJECTION/WEEK INTRAMUSCULAR. During the same period patient was treated with ALCOHOL. Patient was hospitalized and became disabled. Patient recovered.